Bank Of America Corp Oramed Pharmaceuticals Inc. Transaction History

Bank Of America Corp

$1.06 Trillion
Q1 2024

A detailed history of Bank Of America Corp transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Bank Of America Corp holds 287,052 shares of ORMP stock, worth $734,853. This represents 0.0% of its overall portfolio holdings.

Number of Shares

287,052

Previous 271,403 5.77%

Holding current value

$734,853

Previous $626,000 33.87%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.18 - $3.58 $34,114 - $56,023	15,649 Added 5.77%	287,052 $838,000
Q4 2023 Feb 14, 2024	BUY	$1.71 - $2.57 $409,531 - $615,494	239,492 Added 750.5%	271,403 $626,000
Q2 2023 Aug 14, 2023	SELL	$2.12 - $4.47 $53,795 - $113,426	-25,375 Reduced 44.3%	31,911 $114,000
Q1 2023 May 12, 2023	BUY	$1.93 - $13.1 $74,167 - $503,419	38,429 Added 203.79%	57,286 $124,000
Q4 2022 Feb 10, 2023	SELL	$6.21 - $12.03 $38,626 - $74,826	-6,220 Reduced 24.8%	18,857 $226,000

Q3 2022 Nov 14, 2022	SELL	$4.6 - $9.91 $67,436 - $145,280	-14,660 Reduced 36.89%	25,077 $163,000
Q2 2022 Aug 12, 2022	SELL	$3.72 - $9.0 $114,851 - $277,866	-30,874 Reduced 43.72%	39,737 $181,000
Q1 2022 May 16, 2022	SELL	$8.19 - $13.89 $105,806 - $179,444	-12,919 Reduced 15.47%	70,611 $611,000
Q4 2021 Feb 08, 2022	BUY	$12.98 - $29.75 $788,106 - $1.81 Million	60,717 Added 266.15%	83,530 $1.19 Million
Q3 2021 Nov 15, 2021	BUY	$12.13 - $23.82 $38,925 - $76,438	3,209 Added 16.37%	22,813 $502,000
Q2 2021 Sep 13, 2021	BUY	$8.34 - $14.59 $163,497 - $286,022	19,604 New	19,604 $263,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

5.69M

Call Options Held

8.3K

Put Options Held

2.7K

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $99.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Oramed Pharmaceuticals Inc. Transaction History